AAR : The investment held by the Applicant in equity shares of GlaxoSmithKline Asia Private Limited (hereinafter referred to as ‘GSKAPL’) would be considered as ‘capital asset’ under Section 2(14) of the Income-tax Act, 1961 (hereinafter referred to as ‘the Act’)
Authority For Advance Rulings (Income Tax), New Delhi Smithkline Beecham Port Louis Ltd., In Re Section 9, 2(14), 92 TO […]